Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

POVIDONE-IODINE: 1,447 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
1,447
Total FAERS Reports
113 (7.8%)
Deaths Reported
325
Hospitalizations
1,447
As Primary/Secondary Suspect
149
Life-Threatening
114
Disabilities
Dec 17, 1986
FDA Approved
Lights Medical Manufacture ...
Manufacturer
Prescription
Status

Route: TOPICAL · Manufacturer: Lights Medical Manufacture Co., Ltd. · FDA Application: 018634 · HUMAN OTC DRUG · FDA Label: Available

First Report: 1988 · Latest Report: 20250624

What Are the Most Common POVIDONE-IODINE Side Effects?

#1 Most Reported
Drug hypersensitivity
307 reports (21.2%)
#2 Most Reported
Rash
151 reports (10.4%)
#3 Most Reported
Toxic anterior segment syndrome
144 reports (10.0%)

All POVIDONE-IODINE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Drug hypersensitivity 307 21.2% 44 52
Rash 151 10.4% 70 86
Toxic anterior segment syndrome 144 10.0% 0 1
Drug ineffective 131 9.1% 70 88
Off label use 121 8.4% 70 85
Nausea 118 8.2% 47 58
Hypersensitivity 111 7.7% 11 19
Pain 110 7.6% 63 68
Endophthalmitis 104 7.2% 0 14
Eye pain 96 6.6% 4 7
Vomiting 78 5.4% 31 29
Swelling 76 5.3% 67 63
Rheumatoid arthritis 75 5.2% 74 70
Systemic lupus erythematosus 75 5.2% 75 70
Type 2 diabetes mellitus 73 5.0% 70 66
Pericarditis 72 5.0% 71 67
Psoriatic arthropathy 72 5.0% 71 67
Anaphylactic reaction 70 4.8% 0 22
Abdominal discomfort 69 4.8% 29 28
Pemphigus 69 4.8% 68 64

Who Reports POVIDONE-IODINE Side Effects? Age & Gender Data

Gender: 74.0% female, 26.0% male. Average age: 59.2 years. Most reports from: US. View detailed demographics →

Is POVIDONE-IODINE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2000 1 0 0
2001 1 0 0
2002 1 0 0
2005 3 0 0
2007 11 0 0
2008 3 0 0
2009 1 0 1
2010 8 0 7
2011 6 0 3
2012 1 0 1
2013 9 1 1
2014 56 0 6
2015 51 3 15
2016 81 1 10
2017 75 0 30
2018 50 0 24
2019 61 1 22
2020 28 0 6
2021 67 0 21
2022 77 5 13
2023 35 0 12
2024 28 0 7
2025 19 0 2

View full timeline →

What Is POVIDONE-IODINE Used For?

IndicationReports
Product used for unknown indication 606
Preoperative care 134
Infection prophylaxis 102
Cataract operation 43
Antibiotic prophylaxis 39
Intraocular lens implant 37
Surgery 30
Mouth ulceration 29
Postoperative care 17
Intraoperative care 15

POVIDONE-IODINE vs Alternatives: Which Is Safer?

POVIDONE-IODINE vs PRABOTULINUMTOXINA-XVFS POVIDONE-IODINE vs PRADAXA POVIDONE-IODINE vs PRALATREXATE POVIDONE-IODINE vs PRALSETINIB POVIDONE-IODINE vs PRAMIPEXOLE POVIDONE-IODINE vs PRAMIPEXOLE\PRAMIPEXOLE POVIDONE-IODINE vs PRAMLINTIDE POVIDONE-IODINE vs PRASTERONE POVIDONE-IODINE vs PRASUGREL POVIDONE-IODINE vs PRAVASTATIN

Official FDA Label for POVIDONE-IODINE

Official prescribing information from the FDA-approved drug label.

Drug Description

DESCRIPTION: Povidone-Iodine is a broad-spectrum microbicide with the chemical formulas: 2-pyrrolidinone, 1- ethenyl-, homopolymer, compound with iodine; 1-vinyl-2-pyrrolidinone polymer, compound with iodine. The structural formula is as follows: BETADINE* 5% Sterile Ophthalmic Prep Solution contains 5% povidone-iodine (0.5% available iodine) as a sterile dark brown solution stabilized by glycerin.

Inactive

Ingredients: purified water, citric acid, glycerin, nonoxynol-9, sodium chloride, sodium hydroxide, and dibasic sodium phosphate.

FDA Approved Uses (Indications)

Uses Prepping intact skin and mucous membranes prior to surgery

Directions Patient preoperative prep use full strength apply solution to operative site following povidone iodine scrub application using a circular motion, start at incision site and move outward remove all soiled underdrapes do not allow solution to pool

Dosage & Administration

DOSAGE AND ADMINISTRATION: While the inner surface and contents of the immediate container (i.e. bottle) are sterile, the outer surface of the bottle is not sterile. The use of the bottle in a sterile field should be avoided. BETADINE* 5% Sterile Ophthalmic Prep Solution is used as follows: BETADINE* 5% Sterile Ophthalmic Prep Solution is used as follows: Make sure container is intact before use. To open, COMPLETELY TWIST OFF TAB, do not pull off. Gently pour entire contents of bottle into a sterile prep cup. Saturate sterile cotton-tipped applicator to prep lashes and lid margins using one or more applicators per lid; repeat once. Saturate sterile prep sponge or other suitable material to prep lids, brow and cheek in a circular ever-expanding fashion until the entire field is covered; repeat prep three (3) times. While separating the lids, irrigate the cornea, conjunctiva and palpebral fornices with BETADINE* 5% Sterile Ophthalmic Prep Solution using a sterile bulb syringe. After the BETADINE* 5% Sterile Ophthalmic Prep Solution has been left in contact for two minutes, sterile saline solution in a bulb syringe should be used to flush the residual prep solution from the cornea, conjunctiva, and the palpebral fornices.

Contraindications

CONTRAINDICATIONS: Do not use on individuals known to be sensitive to iodine, or other components of this product.

Known Adverse Reactions

ADVERSE REACTION DISTRIBUTED BY TOPCO ASSOCIATES LLC ELK GROVE VILLAGE, IL 60007 ©TOPCO VIJA0622 QUESTIONS? 1-888-423-0139 [email protected] www.topcarebrand.com *This product is not manufactured or distributed by Avrio Health L.P., distributor of Betadine Antiseptic 10% Povidone-Iodine First Aid Antiseptic.

Quality Guaranteed This

TopCare product is laboratory tested to guarantee its highest quality. Your total satisfaction is guaranteed. Scan here for more information or call 1-888-423-0139

Warnings

Warnings SoreThroat Warning: Severe or persistent sore throat or sore throataccompanied by high fever, headache, nausea, and vomiting may be serious.Consult doctor promptly. Do not use more than 2 days or administerto children under 3 years of age unless directed by a doctor. Do not use this product for more than 7 days unless directed by a dentist or doctor if you are allergic to povidone-iodine or any other ingredientsin this product if you have any thyroid conditions When using this product do not get into eyes. If contact occurs, rinse eyes thoroughlywith water. If irritation persists, consult a doctor do not swallow do not use with hydrogen peroxide Stop use and ask a doctor if symptoms do not improve in 7 days irritation, pain, or redness persists or worsens swelling, rash, or fever develops

Precautions

PRECAUTIONS: General: No studies are available in patients with thyroid disorders; therefore, caution is advised in using BETADINE* 5% Sterile Ophthalmic Prep Solution in these patients due to the possibility of iodine absorption. Carcinogenesis, Mutagenesis, Impairment of Fertility: No long term studies in animals have been performed to evaluate the carcinogenic or mutagenic potential of povidone-iodine. One report of the mutagenic potential of povidone-iodine indicated that it was positive in a modification of the Ames S. typhimurium model, but these results could not be reproduced by another researcher. Another test using mouse lymphoma and Balb/3T3 cells showed that povidone-iodine has no significant mutagenic or transformation capabilities. Other data indicated that it does not produce mutagenic effects in mice or hamsters according to the dominant lethal test, micronucleus test, and chromosome analysis. Pregnancy: Animal reproduction studies have not been conducted with BETADINE* 5% Sterile Ophthalmic Prep Solution. It is also not known whether BETADINE* 5% Sterile Ophthalmic Prep Solution can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. BETADINE* 5% Sterile Ophthalmic Prep Solution should only be used on a pregnant woman if clearly needed.

Nursing

Mothers: Because of the potential for serious adverse reactions in nursing infants from BETADINE* 5% Sterile Ophthalmic Prep Solution, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Active Ingredient

Active Ingredients Povidone Iodine 10% USP.

Purpose

First aid to help reduce the risk of infection in minor cuts, scrapes, and burns.

Inactive Ingredients

Inactive Ingredients: ceteareth-25, lactic acid, lauramidopropylamine oxide, malic acid, polyquarternium-10, PPG-5-ceteth-10 phosphate, sodium hydroxide, sodium iodide, water, xylitol